Showing of 439 reports & studies
How global butyl glycol supply is scaling across petrochemical feedstocks, glycol ether production technologies and downstream coatings, cleaning and industrial solvent applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-439
250 pages
Chemicals & Materials
How global C-10 solvent supply is scaling across refinery streams, petrochemical processing routes and downstream coatings, agrochemical and industrial solvent applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-438
250 pages
Chemicals & Materials
How global C9 solvent supply is scaling across refinery streams, aromatics processing routes and downstream coatings, rubber, inks and industrial solvent applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-437
250 pages
Chemicals & Materials
How global ciprofloxacin hydrochloride supply is scaling across synthetic antibiotic manufacturing routes, pharmaceutical production systems and downstream healthcare applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-436
250 pages
Chemicals & Materials
How global citric acid supply is scaling across fermentation feedstocks, microbial processing technologies and downstream food, beverage, pharmaceutical and industrial applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-435
250 pages
Chemicals & Materials
How global clarithromycin supply is scaling across macrolide fermentation, semi-synthetic processing routes and downstream pharmaceutical applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-434
250 pages
Chemicals & Materials
How global clindamycin phosphate supply is scaling across antibiotic fermentation and semi-synthetic conversion routes, pharmaceutical manufacturing hubs and downstream injectable, topical and oral applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-433
250 pages
Chemicals & Materials
How global clofazimine supply is scaling across pharmaceutical synthesis routes, formulation technologies and downstream leprosy, tuberculosis and neglected disease treatment applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-432
250 pages
Chemicals & Materials
How global corn starch supply is scaling across wet milling assets, processing technologies and downstream food, industrial and bio-based applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-431
250 pages
Chemicals & Materials
How global dexamethasone sodium phosphate supply is scaling across steroid synthesis routes, injectable pharmaceutical manufacturing systems and downstream hospital and clinical applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-430
250 pages
Chemicals & Materials
How global dextrose supply is scaling across starch processing hubs, hydrolysis technologies and downstream food, pharmaceutical and industrial applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-429
250 pages
Chemicals & Materials
How global diclofenac sodium supply is scaling across pharmaceutical synthesis routes, formulation technologies and downstream pain management, anti-inflammatory and veterinary applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-428
250 pages
Chemicals & Materials
How global dipropylene glycol monomethyl ether supply is scaling across propylene oxide derivative chemistry, integrated petrochemical systems and downstream industrial and specialty applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-427
250 pages
Chemicals & Materials
How global doxepin hydrochloride supply is scaling across pharmaceutical synthesis routes, formulation technologies and downstream mental health, sleep disorder and dermatological applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-426
250 pages
Chemicals & Materials
How global doxycycline hydrochloride supply is scaling across antibiotic fermentation routes, API manufacturing systems and downstream pharmaceutical applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-425
250 pages
Chemicals & Materials
How global enoxaparin sodium supply is scaling across heparin fractionation routes, biologically derived API manufacturing hubs and downstream anticoagulant pharmaceutical applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-424
250 pages
Chemicals & Materials
How global epinephrine supply is scaling across pharmaceutical synthesis routes, sterile manufacturing systems and downstream emergency, hospital and consumer health applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-423
250 pages
Chemicals & Materials
How global erucic acid supply is scaling across oilseed cultivation, fatty acid processing technologies and downstream industrial, chemical and specialty material applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-422
250 pages
Chemicals & Materials
How global erythromycin supply is scaling across fermentation-based API manufacturing hubs, process technologies and downstream pharmaceutical applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-421
250 pages
Chemicals & Materials
How global ethoxylated tridecyl alcohol supply is scaling across fatty alcohol feedstocks, ethoxylation technologies and downstream detergents, cleaners and industrial surfactant applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-420
250 pages
Chemicals & Materials
How global ethylene acrylic acid copolymer supply is scaling across petrochemical feedstocks, polymerisation technologies and downstream packaging, industrial and specialty material applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-419
250 pages
Chemicals & Materials
How global fluconazole supply is scaling across API manufacturing hubs, synthetic process routes and downstream pharmaceutical applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-418
250 pages
Chemicals & Materials
How global fluorspar supply is scaling across mining operations, beneficiation technologies and downstream chemical, metallurgical and industrial applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-417
250 pages
Chemicals & Materials
How global fly ash supply is evolving alongside coal-fired power generation, beneficiation technologies and downstream construction and industrial applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-416
250 pages
Chemicals & Materials
How global fumed silica supply is evolving across flame hydrolysis production systems, specialty materials manufacturing hubs and downstream performance-driven applications, where production capacity is concentrated, and what growth drivers and risks executives monitor.
January 2026
REP-GB-415
250 pages
Chemicals & Materials
How global gentamicin sulfate supply is scaling across fermentation capacity, antibiotic active pharmaceutical ingredient (API) manufacturing and downstream human and veterinary pharmaceutical applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-414
250 pages
Chemicals & Materials
How global glutaraldehyde supply is scaling across petrochemical feedstocks, aldehyde synthesis technologies and downstream industrial, healthcare and water treatment applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-413
250 pages
Chemicals & Materials
How global graphite supply is scaling across mining assets, beneficiation and purification technologies, battery material processing and downstream industrial applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-412
250 pages
Chemicals & Materials
How global Hastelloy supply is scaling across nickel-based superalloy melting routes, downstream industrial fabrication and high-performance end-use sectors, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-411
250 pages
Chemicals & Materials
How global iso-butyric acid supply is scaling across petrochemical and bio-based production routes, downstream chemical intermediates and specialty applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-410
250 pages
Chemicals & Materials
How global ivermectin supply is shaped by fermentation capacity, pharmaceutical manufacturing systems and downstream human and veterinary applications, where production clusters are concentrated, and what growth drivers and risks industry stakeholders need to monitor.
January 2026
REP-GB-409
250 pages
Chemicals & Materials
How global lactic acid supply is scaling across fermentation feedstocks, bioprocessing technologies and downstream food, pharmaceutical and bioplastics applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-408
250 pages
Chemicals & Materials
How global levocetirizine dihydrochloride supply is scaling across pharmaceutical synthesis routes, regulatory manufacturing frameworks and downstream allergy and respiratory therapeutics, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-407
250 pages
Chemicals & Materials
How global levofloxacin hemihydrate supply is scaling across synthetic and chiral resolution routes, pharmaceutical manufacturing hubs and downstream oral and injectable antibiotic applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-406
250 pages
Chemicals & Materials
How global lincomycin hydrochloride supply is evolving across fermentation capacity, pharmaceutical manufacturing systems and downstream therapeutic applications, where production clusters are located, and what growth drivers and risks industry stakeholders need to monitor.
January 2026
REP-GB-405
250 pages
Chemicals & Materials
How global lithium metal supply is scaling across brine and mineral feedstocks, conversion and refining technologies and downstream battery, chemical and specialty applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-404
250 pages
Chemicals & Materials
How global lopinavir supply is scaling across API synthesis routes, regulatory manufacturing hubs and downstream pharmaceutical applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-403
250 pages
Chemicals & Materials
How global lorazepam supply is shaped by API synthesis capacity, regulated pharmaceutical manufacturing and downstream clinical applications, where production clusters are located, and what growth drivers and risks industry stakeholders need to monitor.
January 2026
REP-GB-402
250 pages
Chemicals & Materials
How global losartan potassium supply is scaling across API synthesis routes, formulation demand and regulated pharmaceutical markets, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-401
250 pages
Chemicals & Materials
How global lovocetirizine dihydrochloride supply is scaling across pharmaceutical synthesis routes, regulatory manufacturing frameworks and downstream allergy and respiratory therapeutics, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-400
250 pages
Chemicals & Materials
How global magnesium chloride supply is scaling across natural brines, seawater extraction and chemical synthesis routes and downstream industrial, construction and environmental applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-399
250 pages
Chemicals & Materials
How global magnesium stearate supply is scaling across fatty acid feedstocks, excipient manufacturing technologies and downstream pharmaceutical, nutraceutical and industrial applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-398
250 pages
Chemicals & Materials
How global methyl-n-propyl-ketone supply is scaling across petrochemical feedstocks, solvent production routes and downstream industrial applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-397
250 pages
Chemicals & Materials
How global methyldopa supply is scaling across API synthesis routes, pharmaceutical manufacturing hubs and downstream antihypertensive applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-396
250 pages
Chemicals & Materials
How global metoclopramide hydrochloride supply is scaling across active pharmaceutical ingredient manufacturing hubs, synthesis technologies and downstream formulation applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-395
250 pages
Chemicals & Materials
How global metoprolol succinate supply is scaling across active pharmaceutical ingredient manufacturing, controlled-release formulation technologies and downstream cardiovascular therapy demand, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-394
250 pages
Chemicals & Materials
How global metronidazole supply is scaling across pharmaceutical manufacturing hubs, synthesis routes and downstream therapeutic applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-393
250 pages
Chemicals & Materials
How global mineral turpentine oil supply is scaling across refinery streams, hydrocarbon processing routes and downstream industrial, coatings and household applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-392
250 pages
Chemicals & Materials
How global minoxidil supply is scaling across active pharmaceutical ingredient manufacturing, topical formulation technologies and downstream dermatology and cardiovascular applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-391
250 pages
Chemicals & Materials
How global moxifloxacin hydrochloride supply is scaling across synthetic pharmaceutical manufacturing routes, regulated API production hubs and downstream human healthcare applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-390
250 pages
Chemicals & Materials
